cilostazol (Pacific Pharmaceuticals)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namecilostazol (Pacific Pharmaceuticals)
Drug Alias NamePP-101 (Pacific Pharmaceuticals)
ClassificationSmall molecules
Mechanisms of ActionCoagulation factor inhibitorsPhosphodiesterase 3 inhibitors
TargetsPhosphodiesterase 3Coagulation factor
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPacific Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPacific Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A